# Effect of Atorvastatin on Subclinical Atherosclerosis

> **NCT04101136** · NA · UNKNOWN · sponsor: **Dr Cipto Mangunkusumo General Hospital** · enrollment: 80 (estimated)

## Conditions studied

- CMV

## Interventions

- **DRUG:** Atorvastatin - placebo controlled clinical trial

## Key facts

- **NCT ID:** NCT04101136
- **Lead sponsor:** Dr Cipto Mangunkusumo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-30
- **Primary completion:** 2020-07-15
- **Final completion:** 2021-07-15
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04101136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04101136, "Effect of Atorvastatin on Subclinical Atherosclerosis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04101136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*